74°
Baton Rouge, Louisiana
7 Day Forecast

Latest Weather Blog

Follow our weather team on social media

FDA OKs 1st generic nasal spray of overdose reversal drug

5 months 3 weeks 4 days ago Friday, April 19 2019 Apr 19, 2019 April 19, 2019 3:21 PM April 19, 2019 in News
Source: Associated Press
U.S. regulators have approved the first generic nasal spray version of Narcan, a drug that reverses opioid overdoses.
  
The Food and Drug Administration on Friday OK'd naloxone spray from Israel's Teva Pharmaceuticals.
  
Naloxone has been sold as a nasal spray in the U.S. since 2016 under the brand name Narcan. Pharmacists can dispense it without a prescription. It is also sold as a generic or brand-name drug in automatic injectors, prefilled syringes and vials.
  
A pack of two Narcan nasal sprays cost about $130 to $150 without insurance. Teva didn't immediately provide the product's price or when it will be available; its offices were closed Friday.
  
More than 47,600 Americans died of opioid overdoses in 2017, a toll that has been rising for two decades.

More News

Desktop News

Click to open Continuous News in a sidebar that updates in real-time.
Radar
7 Days